Penny Stocks
Onco-Innovations’ Share-Linked Payment Plan Threatens Dilution Even as Nanosoft Boosts ONC010 Manufacturing
The gulf between operational progress and market perception is rarely wider than at Onco-Innovations these days. The oncology biotech has...
Critical One Energy Drills Confirm Antimony Zone as Junior Miner Eyes Strategic Metals Supply
The race to secure Western supply chains for critical minerals is heating up, and Critical One Energy is positioning itself...
Graphite One Grants Millions in Options Despite 46% Stock Rout as Ohio and Alaska Project Clocks Tick
The board of Graphite One has authorised nearly 5.6 million new stock options for its executive team, splitting them evenly...
Rock Tech Lithium Secures Mandate for Reverse Share Consolidation as Dual-Continent Strategy Intensifies
Shareholders of Rock Tech Lithium have handed the board broad authority to execute a reverse stock split, voting 98.54% in...
Graphite One Stock Sinks to Oversold Territory as Shareholders Greenlight Reverse Split and Executive Options
Graphite One shareholders have voted to authorize a reverse stock split of up to 10-for-1, clearing a critical hurdle for...
Outlook Therapeutics Clears Nasdaq Hurdle but Faces $39M Debt and FDA Deadline
Outlook Therapeutics has escaped the threat of expulsion from the Nasdaq Capital Market, but the relief is tempered by a...
Quantum eMotion’s First Revenue Arrives, But the Market Wants More Than Promises
For a company whose stock has swung by an annualised 95% over the past 30 trading days, the arrival of...
Battalion Oil’s Dual Catalysts: Index Inclusion Meets Geopolitical Lift
The rollercoaster ride for Battalion Oil shareholders shows no signs of letting up, but the past two sessions have at...
NEO Battery Materials Plots a Drone-Fueled Turnaround as Shares Wobble Near Lows
NEO Battery Materials is repositioning itself at the intersection of defense technology and advanced energy storage, betting heavily on specialized...
Ocugen’s Insider and Institutional Conviction Rises as a Dense Timeline of Gene Therapy Catalysts Approaches
Ocugen enters a make-or-break stretch that will test both its science and its stock. The gene therapy developer, which has...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
